Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingre Zaoshi Liangxue Fang (QRZSLXF) is a traditional Chinese medicinal herb recipe composed of five quality-assured herbs: Sophora flavescens Aiton., Baphicacanthus cusia (Nees) Bremek., Bletilla striata Rchb.f., Glycyrrhiza uralensis Fisch., and Coptis chinensis Franch. Its main phytochemical ingredients include ammothamnine, sophocarpidine, liquiritin, berberine, and indirubin. QRZSLXF has been clinically used for over two decades in the treatment of ulcerative colitis, with research confirming its therapeutic effects and partially elucidating its mechanism of action, specifically its intervention on the DOR-β-arrestin1-Bcl2 signal transduction pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingre Zaoshi Liangxue Fang.